MGTX
MeiraGTx Holdings PLC
NASDAQ: MGTX · HEALTHCARE · BIOTECHNOLOGY
$9.75
+3.72% today
Updated 2026-10-28
Market cap
$884.56M
P/E ratio
10.71
P/S ratio
2.23x
EPS (TTM)
$0.86
Dividend yield
—
52W range
$7 – $15
Volume
0.9M
MeiraGTx Holdings PLC (MGTX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$9.75
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 10.71x (capped 25x) · Margin: 19.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.